Bio Medica Laboratories Ltd.

The Bio Medica Laboratories Ltd. IPO has a total issue size of ₹52 crore, calculated at the upper end of the price band.

The Bio Medica Laboratories Ltd. IPO is priced at ₹132–139 per share. Retail bids must fall within this price band, against a face value of ₹10 per share.

The lot size for the Bio Medica Laboratories Ltd. IPO is 2,000 shares, which is also the minimum order quantity — you have to apply for at least 2,000 shares, and in multiples of 2,000 beyond that.

The minimum investment in the Bio Medica Laboratories Ltd. IPO is about ₹2,64,000 — one lot of 2,000 shares, calculated at the lower end of the price band.

Bidding at the cut-off or upper price raises the amount blocked in your account.

The Bio Medica Laboratories Ltd. IPO opens on 21 May 2026 and closes on 25 May 2026.

Applications have to be in before 5:00 PM IST on the closing day, and your UPI mandate needs to be approved by then as well.

Bio Medica Laboratories Ltd. shares were listed on 29 May 2026 on NSE.

Skyline Financial Services Pvt Ltd is the registrar for the Bio Medica Laboratories Ltd. IPO.

The registrar processes the basis of allotment, refunds and the credit of shares to your demat account, so allotment-status queries go to them — phone 011-26847136/26833777.

Bio Medica Laboratories Ltd. IPO shares are listed on NSE.

Each Bio Medica Laboratories Ltd. share has a face value of ₹10.

Face value is the nominal value recorded in the company's books and is separate from the issue price you pay.

Promoters held 96.84% of Bio Medica Laboratories Ltd. before the IPO, which falls to 67.69% after the issue.

37,72,000 shares of Bio Medica Laboratories Ltd. are being offered to the public in this issue.

1. 1.To meet out the Repayment of Loan
2. 2.Enhancement of its existing production capabilities by setting up of new manufacturing facility at theexisting premises
3. 3.To meet out the General Corporate Purposes

Narnolia Financial Services Ltd. is the book running lead manager for the Bio Medica Laboratories Ltd. IPO.

Pre-apply means placing your Bio Medica Laboratories Ltd. IPO application before the subscription window actually opens. The bid is held and forwarded to the exchange on the opening day, so you don't have to submit it in the rush of the first morning.

Applying early doesn't improve your chances — when an issue is oversubscribed, the basis of allotment for retail investors is decided by a lottery, not by who applied first. Your money is only blocked once the application reaches the exchange.

You can apply in the Bio Medica Laboratories Ltd. IPO online using either UPI or ASBA as the payment method. ASBA applications are made through the net banking of a bank account that supports IPO applications — the bank blocks the amount in your account instead of debiting it. UPI applications are offered by brokers that don't provide banking services: you enter your UPI ID and then approve the mandate request in your UPI app.

Either route needs a demat account. You bid for at least one lot, at a price within the price band or at the cut-off price, and the money stays blocked in your bank account until the basis of allotment is finalised.

Your broker or bank confirms the bid once it has been submitted to the exchange, usually within a few minutes during the bidding window. A UPI application only goes live after you approve the mandate request — ignore it and the bid lapses, even though it looks placed.

You can check the Bio Medica Laboratories Ltd. IPO bid independently on the NSE or BSE IPO bid-verification page a day after applying. An ASBA application also shows up as a blocked amount in your bank statement.